Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
12.98
-0.01 (-0.08%)
Jun 1, 2026, 1:20 PM EDT - Market open
Pharming Group Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 369.45 | 376.13 | 297.2 | 245.32 | 205.62 | 198.87 | |
Revenue Growth (YoY) | 15.20% | 26.56% | 21.15% | 19.30% | 3.40% | -6.27% |
Cost of Revenue | 43.84 | 45.5 | 35.4 | 25.21 | 17.56 | 21.14 |
Gross Profit | 325.6 | 330.63 | 261.8 | 220.1 | 188.06 | 177.73 |
Selling, General & Admin | 199.43 | 210.95 | 189.45 | 179.93 | 131.82 | 96.42 |
Research & Development | 104.76 | 100.37 | 83.15 | 68.91 | 52.53 | 70.37 |
Other Operating Expenses | 297.71 | 304.79 | 270.42 | 225.49 | 169.83 | 164.17 |
Total Operating Expenses | 601.91 | 616.11 | 543.02 | 474.33 | 354.18 | 330.96 |
Operating Income | 27.89 | 25.84 | -8.62 | -5.39 | 18.23 | 13.56 |
Interest Income | 6.95 | 2.8 | 5.08 | 3.37 | 3.4 | 15.59 |
Interest Expense | -7.4 | -18.14 | -9.94 | -9.07 | -5.46 | -6.19 |
Other Non-Operating Income (Expense) | - | 2.35 | 4.99 | -0.93 | -1.19 | 0.11 |
Total Non-Operating Income (Expense) | -0.44 | -13 | 0.13 | -6.63 | -3.25 | 9.52 |
Pretax Income | 19.85 | 12.85 | -8.49 | -12.01 | 14.99 | 23.08 |
Provision for Income Taxes | -5.16 | -10.31 | -3.35 | 1.46 | -1.31 | -7.08 |
Net Income | 12.19 | 2.85 | -11.84 | -10.55 | 13.67 | 16 |
Minority Interest in Earnings | - | -0.31 | - | - | - | - |
Net Income to Common | 12.19 | 2.85 | -11.84 | -10.55 | 13.67 | 16 |
Net Income Growth | - | - | - | - | -14.52% | -57.62% |
Shares Outstanding (Basic) | 64 | 69 | 67 | 66 | 65 | 64 |
Shares Outstanding (Diluted) | 76 | 75 | 79 | 73 | 71 | 70 |
Shares Change (YoY) | -1.73% | -4.91% | 8.26% | 2.59% | 0.85% | 2.70% |
EPS (Basic) | 0.19 | 0.04 | -0.18 | -0.16 | 0.21 | 0.25 |
EPS (Diluted) | 0.16 | 0.04 | -0.18 | -0.16 | 0.19 | 0.23 |
EPS Growth | - | - | - | - | -17.39% | -58.18% |
Shares Outstanding | 70.17 | 70.17 | 68.03 | 67.11 | 65.63 | 64.87 |
Free Cash Flow | 55.72 | 53.96 | -2.59 | -18.74 | 21.08 | 27.1 |
Free Cash Flow Growth | 3.27% | - | - | - | -22.21% | -65.68% |
Free Cash Flow Per Share | 0.73 | 0.72 | -0.03 | -0.26 | 0.30 | 0.39 |
Gross Margin | 88.13% | 87.90% | 88.09% | 89.72% | 91.46% | 89.37% |
Operating Margin | 7.55% | 6.87% | -2.90% | -2.20% | 8.87% | 6.82% |
Profit Margin | 3.30% | 0.67% | -3.98% | -4.30% | 6.65% | 8.04% |
FCF Margin | 15.08% | 14.35% | -0.87% | -7.64% | 10.25% | 13.63% |
EBITDA | 39.64 | 37.06 | 7.45 | 10.54 | 31.42 | 33.17 |
EBITDA Margin | 10.73% | 9.85% | 2.51% | 4.30% | 15.28% | 16.68% |
EBIT | 27.89 | 25.84 | -8.62 | -5.39 | 18.23 | 13.56 |
EBIT Margin | 7.55% | 6.87% | -2.90% | -2.20% | 8.87% | 6.82% |
Effective Tax Rate | -25.99% | -80.25% | 39.44% | -12.19% | -8.76% | -30.69% |